Showing results (21-30 of 94) with videos related to
Sort By:
Pageof 10
Trials|August 5, 2016
Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trialPatricia Hafner, Ulrike Bonati, Daniela Rubino, et al.Journal of Neurology|February 3, 2012
Quantitative MRI can detect subclinical disease progression in muscular dystrophyArne Fischmann, Patricia Hafner, Susanne Fasler, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 6, 2019
Psychosocial adjustment and parental stress in Duchenne Muscular DystrophyVanya Gocheva, Simone Schmidt, Anna-Lena Orsini, et al.Trials|March 10, 2017
Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomised, placebo-controlled, double-blind trialSimone Schmidt, Vanya Gocheva, Thomas Zumbrunn, et al.Trials|November 23, 2019
Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trialSara Nagy, Patricia Hafner, Simone Schmidt, et al.Pharmaceuticals (Basel, Switzerland)|October 17, 2020
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?Stephanie Kourakis, Cara A Timpani, Judy B de Haan, et al.Redox Biology|November 27, 2020
Targeting Nrf2 for the treatment of Duchenne Muscular DystrophyStephanie Kourakis, Cara A Timpani, Judy B de Haan, et al.Amino Acids|July 14, 2018
Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implicationsErik Hanff, Patricia Hafner, Alexander Bollenbach, et al.Scientific Reports|March 7, 2023
Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markersElena C Gross, Niveditha Putananickal, Anna-Lena Orsini, et al.Orphanet Journal of Rare Diseases|March 5, 2021
Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?Stephanie Kourakis, Cara A Timpani, Dean G Campelj, et al.Pageof 10